Hi Wasabi,
Thanks for starting a media thread, I think we are going to need this in the near future.
I watched this interview this morning, a recap for most of us, but good information for new investors especially around the unmet clinical need in FSGS.
Just as an aside here, can’t remember if we already discussed this, but Pfizer canned a Ph2 trial in FSGS fairly recently. If we are successful in ACTION 3 I think we will see a lot of interest from BP.
https://www.clinicaltrialsarena.com/features/pipeline-moves-pfizer-focal-segmental-glomerulosclerosis/As per discussion around the remaining 80% of the globe for licencing deals on the table, I think someone else mentioned previously…but I picked up on that big smile on Nina’s face when she said they have been very busy lately & looking forward to updating the market in due course. So it’s body language, it could mean nothing but it was noticeable - Nina looked excited. I have watched a lot of her interviews. See what others think.
Have a great day All.
(20min delay)